agilon health, inc. (NYSE:AGL) Receives $7.81 Average PT from Analysts

agilon health, inc. (NYSE:AGLGet Free Report) has earned a consensus rating of “Hold” from the twenty ratings firms that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $7.81.

A number of analysts recently commented on the company. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Royal Bank of Canada restated an “outperform” rating and set a $8.00 price target on shares of agilon health in a report on Wednesday, August 7th. Evercore ISI dropped their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a report on Tuesday, October 8th. Benchmark reissued a “buy” rating and set a $9.00 price target on shares of agilon health in a research note on Thursday, August 8th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research report on Friday, August 9th.

Read Our Latest Report on agilon health

Insiders Place Their Bets

In other news, CEO Steven Sell purchased 20,000 shares of the stock in a transaction on Thursday, September 12th. The stock was bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the transaction, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.20% of the stock is currently owned by insiders.

Institutional Investors Weigh In On agilon health

Large investors have recently bought and sold shares of the company. Capital International Investors boosted its holdings in shares of agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after purchasing an additional 9,263,296 shares during the last quarter. AQR Capital Management LLC lifted its stake in agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares in the last quarter. Susquehanna Fundamental Investments LLC acquired a new position in agilon health during the first quarter worth $2,975,000. Vanguard Group Inc. lifted its stake in agilon health by 1.3% during the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after purchasing an additional 371,537 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of agilon health during the second quarter worth $1,849,000.

agilon health Price Performance

agilon health stock opened at $2.73 on Tuesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36. The business’s fifty day simple moving average is $3.33 and its two-hundred day simple moving average is $5.01. agilon health has a 12 month low of $2.36 and a 12 month high of $13.76.

agilon health (NYSE:AGLGet Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, hitting the consensus estimate of ($0.07). The firm had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The company’s revenue was up 38.7% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.04) earnings per share. Equities analysts expect that agilon health will post -0.32 earnings per share for the current year.

About agilon health

(Get Free Report

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Analyst Recommendations for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.